Aberrant hnRNPK expression in the cytoplasm has been reported in pancreatic cancer 15, colorectal cancer 16, prostate cancer 17, and renal cell carcinoma 18, and was associated with poor clinical prognosis. The gene discussed is HNRNPK; the disease is prostate cancer.